Comprehensive analysis of morbidity and mortality patterns in familial partial lipodystrophy patients: insights from a population study
Open Access
- 3 June 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 15, 1359211
Abstract
Background: There is a lack of information on the clinical and molecular presentation of familial partial lipodystrophy (FPLD), a rare genetic disorder characterized by partial subcutaneous fat loss.Objective: This study aimed to provide a comprehensive assessment of the clinical, metabolic, and genetic features of FPLD in the Brazilian population.Methods: In a multicenter cross-sectional investigation we evaluated patients with FPLD across five Brazilian reference centers for lipodystrophies. Diagnosis of FPLD was made by clinical evaluation and genetic confirmation. Data on genetic, clinical, and metabolic characteristics were captured. Statistical analysis involved the utilization of the Kruskal-Wallis test to identify differences.Results: The study included 106 patients with genetic confirmation of FPLD. The mean age was 44 ± 15 years, and they were predominantly female (78.3%). LMNA pathogenic variants were identified in 85.8% of patients, PPARG in 10.4%, PLIN1 in 2.8%, and MFN2 in 0.9%. Diabetes mellitus (DM) was highly prevalent (57.5%), affecting 54 females (50.9%). Median triglycerides levels were 199 mg/dL (54–2724 mg/dL), severe hypertriglyceridemia (≥ 500 mg/dL) was found in 34.9% and pancreatitis in 8.5%. Metabolic-associated fatty liver disease (MAFLD) was observed in 56.6%, and cardiovascular disease in 10.4%. The overall mortality rate was 3.8%, due to cardiovascular events.Conclusion: This study presents an extensive cohort of Brazilian patients with FPLD, predominantly DM with several multisystem complications. A comprehensive characterization of lipodystrophy syndromes is crucial for effective patient management and care.Keywords
This publication has 18 references indexed in Scilit:
- Deciphering the Clinical Presentations in LMNA-related Lipodystrophy: Report of 115 Cases and a Systematic ReviewThe Journal of Clinical Endocrinology & Metabolism, 2023
- Phenotypic Differences Among Familial Partial Lipodystrophy Due to LMNA or PPARG VariantsJournal of the Endocrine Society, 2022
- Cardiac phenotype in familial partial lipodystrophyClinical Endocrinology, 2021
- Diagnostic strategies and clinical management of lipodystrophyExpert Review of Endocrinology & Metabolism, 2020
- Early Left Ventricular Systolic Dysfunction Detected by Two-Dimensional Speckle-Tracking Echocardiography in Young Patients with Congenital Generalized LipodystrophyDiabetes, Metabolic Syndrome and Obesity, 2020
- What lipodystrophies teach us about the metabolic syndromeJournal of Clinical Investigation, 2019
- Homozygous and Heterozygous Nuclear Lamin A p.R582C Mutation: Different Lipodystrophic Phenotypes in the Same KindredFrontiers in Endocrinology, 2018
- Diagnosis and treatment of lipodystrophy: a step-by-step approachJournal of Endocrinological Investigation, 2018
- Estimating the prevalence of generalized and partial lipodystrophy: findings and challengesDiabetes, Metabolic Syndrome and Obesity, 2017
- A New Method for Body Fat Evaluation, Body Adiposity Index, Is Useful in Women With Familial Partial LipodystrophyObesity, 2012